Intervention component | Purpose | Content |
---|---|---|
Video for Patients | 1) To describe key messages about prostate cancer screening | 1) Key messages: |
· There are two kinds of prostate cancer—harmless and dangerous | ||
· A problem with the PSA test is that it leads some men with a harmless prostate cancer to get treatment that they do not need. | ||
· About half of all men who get treatment for prostate cancer will have permanent side effects | ||
· Men should decide whether the PSA test is right for them and talk with their doctor. | ||
2) To model the process of learning and deciding about prostate cancer screening | 2) Modeling: | |
· 4 men engage in an after-hours discussion with their physician | ||
· Each man participates in questioning and reasoning about screening | ||
3) To facilitate values clarification via a process of social matching with two men making opposite decisions using the same facts | Values Clarification: | |
· Joe decides to get the PSA test after considering the facts | ||
· Frank decides NOT to get the PSA test after considering the facts | ||
Coaching Session for Patients | 1) To answer men’s questions about prostate cancer screening by providing a supplemental educational brochure | 1) Key facts: |
· Location of the prostate | ||
· Characteristics of the PSA test | ||
· Characteristics of prostate cancer | ||
· Risk factors for prostate cancer | ||
· Treatment options and their side effects | ||
2) To help men clarify their values for screening by ranking and rating decisional attributes | 2) Decisional Attributes: | |
· Magnitude of the problem (e.g. prostate cancer) | ||
· Benefit in knowing one has prostate cancer | ||
· The (un)certainty of the PSA test | ||
· The (un)certainty of treatment outcomes | ||
· Worry about treatment side effects | ||
3) To help men prepare for a discussion with their doctor by delivering tailored messages about discussion barriers and by providing a pad on which to write their screening decision and any questions for their doctor | 2) Barriers to Discussion: | |
· Discomfort asking questions | ||
· Fear of expressing opinions | ||
· Difficulty interrupting the doctor | ||
· Difficulty disagreeing with the doctor | ||
· Worry about taking too much of the doctor’s time | ||
· Difficulty understanding medical jargon | ||
· Embarrassment asking questions | ||
Education Session for Providers | 1) To review the evidence for prostate cancer screening | 1) Evidence: |
· Natural History of prostate cancer | ||
· Lack of clear benefit of prostate cancer screening | ||
· Certain harms of screening and early treatment | ||
2) To highlight the value of shared decision making for prostate cancer screening | 2) Value of Shared Decision Making: | |
· Ethical obligation to consider patient preferences in the face of uncertain outcomes |